With stem cell therapy bringing radical change in treatment against human diseases, more and more parents are considering stem cell banking as an health insurance policy against fatal diseases.
The increasing appeal for stem cell banking in India received a boost with Europe’s largest stem cell banking company, Cryo-Save launching its operation in India from December. Realizing India’s potential with a population over billion people, the company has set 10 stem cell storage banks in the country this month ,at a cost of Rs 10 million. Cryo-Save has already tied with hospitals and gynaecologists to inform the expecting mothers about the merits of stem cell banking. However, some of the India companies like LifeCell in Chennai and Reliance Life Science have also been involved in stem cell banking.
Umbilical cord blood cells has been used for years in treatment of blood disorders, red cell disorders, malignant tumors, leukaemia and other disorders. At present researches are being conducted to to use stem cells for treatment of more than 85 diseases.
Stem cells provide a natural means of treating disorders in human body. It needs a mention that over 10,000 patients from 150 countries have been treated through transplantation of cord blood stem cells.
Cryo-Save would be the first of its kind in India to offer fully automated dual-storage system. this implies that the stem cells would be stored in two different packets, making it usable for second time. The company also offers multi-storage facilities which will allow the stem cells from the baby to be used for treating other family members. Improved stem cell banking facilities are expected to mark a new beginning of stem cell therapy in the Indian.
Source: The Hindu